GALAPAGOS NV (LKFT)
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
OLEMA PHARMACEUTICALS, INC. (OLMA)
Olema Oncology Reports Second Quarter 2026 Financial and Operating Results
MESA LABORATORIES INC /CO/ (MLAB)
Mesa Labs Announces First Quarter Results
ALPHA TAU MEDICAL LTD. (DRTS)
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates
C4 THERAPEUTICS, INC. (CCCC)
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
IN8BIO, INC. (INAB)
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ENANTA PHARMACEUTICALS INC (ENTA)
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
SILENCE THERAPEUTICS PLC (SLN)
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
SEPTERNA, INC. (SEPN)
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results